NCT01896596View on ClinicalTrials.gov

Hepatitis B Vaccination in Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Meningococcal DiseasePneumococcal DiseaseHaemophilus Influenzae Serotype b DiseaseDiphtheria, Tetanus and PertussisHepatitis b
Interventions
BIOLOGICAL

Menjugate

Administered with routine vaccinations at 3 months of age

BIOLOGICAL

Menitorix

Administered with routine vaccinations at 3 months

BIOLOGICAL

NeisVac-C

Administered with routine vaccinations at 3 months

Trial Locations (1)

Unknown

St George's Vaccien Institute, London

All Listed Sponsors
collaborator

Department of Health, United Kingdom

OTHER_GOV

collaborator

Institute of Child Health, London, England

UNKNOWN

lead

Public Health England

OTHER_GOV

NCT01896596 - Hepatitis B Vaccination in Infants | Biotech Hunter | Biotech Hunter